← Open Payments lookup

ELIZABETH BAUMANN: Open Payments

NPI 1356961817 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,571 in 68 payments from 16 companies in 2025. Trend: 2023 $2,412 · 2024 $2,621 · 2025 $1,571

Food & beverage: $1,571
CompanyPaymentsAmount
GlaxoSmithKline, LLC.12$286
AstraZeneca Pharmaceuticals LP9$189
Mallinckrodt Hospital Products Inc.7$155
Takeda Pharmaceuticals U.S.A., Inc.5$148
GENZYME CORPORATION6$132
Grifols USA, LLC5$120
Boehringer Ingelheim Pharmaceuticals, Inc.5$112
Regeneron Healthcare Solutions, Inc.4$107
CSL Behring3$72
Philips North America LLC3$63

Products named: DUPIXENT, NUCALA, ACTHAR, GLASSIA, Prolastin-C Liquid, OFEV, TRELEGY ELLIPTA, Hizentra.

Industry payments across AL — which companies pay providers there.